Prosecution Insights
Last updated: April 19, 2026

Janssen Sciences Ireland Unlimited Company

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18565725 FUSED HETEROCYCLIC DERIVATIVES HOWELL, THEODORE R 1628 Non-Final OA Nov 30, 2023
18459394 GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF CHANDRA, GYAN 1674 Non-Final OA Aug 31, 2023
18037204 TREATMENT OR PREVENTION OF HIV INFECTION SWIFT, CANDICE LEE 1657 Final Rejection May 16, 2023
17596538 Recombinant Interleukin 12 Construct and Uses Thereof GURLEY, JAMI MICHELLE 1647 Final Rejection Dec 13, 2021

Managing Janssen Sciences Ireland Unlimited Company's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month